cranberry powder

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• age-related cognitive decline [Insufficient Evidence]
• BPH [Insufficient Evidence]
• cancer [Insufficient Evidence]
• cancer prevention, prostate [Insufficient Evidence]
• cardiovascular disease prevention [Insufficient Evidence]
• chronic fatigue syndrome [Insufficient Evidence]
• cystitis prevention, radiation-induced [Insufficient Evidence]
• dental caries [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• H. pylori infection [Insufficient Evidence]
• HTN [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• infection, catheter-related [Insufficient Evidence]
• memory [Insufficient Evidence]
• metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
• metabolic syndrome [Insufficient Evidence]
• nephrolithiasis [Insufficient Evidence]
• obesity [Insufficient Evidence]
• overactive bladder [Insufficient Evidence]
• periodontitis [Insufficient Evidence]
• peristomal lesion [Insufficient Evidence]
• rheumatoid arthritis [Insufficient Evidence]
• URI [Insufficient Evidence]
• urinary deodorizer [Insufficient Evidence]
• UTI prevention [Possibly Effective]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

age-related cognitive decline

[Insufficient Evidence]

Dose: 4.5 g PO bid

BPH

[Insufficient Evidence]

Dose: 500 mg PO tid; Alt: 250-500 mg PO qd

cancer prevention, prostate

[Insufficient Evidence]

Dose: 1500 mg PO qd

cardiovascular disease prevention

[Insufficient Evidence]

Dose: 500 mL/day (27% cranberry) juice PO divided qd-bid

cystitis prevention, radiation-induced

[Insufficient Evidence]

Dose: 200 mg PO qd

H. pylori infection, adult patients

[Insufficient Evidence]

Dose: 480-500 mL/day juice PO divided bid; Alt: 250 mL juice PO qd; Info: used with or without standard tx

H. pylori infection, peds patients

[Insufficient Evidence]

Dose: 200 mL juice PO qd; Info: for patients 6-16 yo; used with lactobacillus johnsonii

hyperlipidemia

[Insufficient Evidence]

Dose: 300 mL juice PO qd; Info: juice containing 25:15:10:50 chokeberry:blueberry:cranberry:apple ratio

metabolic dysfunction-associated steatotic liver disease

[Insufficient Evidence]

Dose: 144 mg PO qd

metabolic syndrome

[Insufficient Evidence]

Dose: 240 mL juice PO bid

nephrolithiasis

[Insufficient Evidence]

Dose: 500 mL juice PO qd; Info: dilute with 1500 mL water

overactive bladder

[Insufficient Evidence]

Dose: 500 mg PO qd

periodontitis

[Insufficient Evidence]

Dose: apply 2.5 g extract gel topically x1 after scaling and root planing; Info: used with garcinia

rheumatoid arthritis

[Insufficient Evidence]

Dose: 250 mL juice PO bid; Info: used with fish oil

URI

[Insufficient Evidence]

Dose: 450 mL juice PO qd

urinary deodorizer

[Insufficient Evidence]

Dose: up to 237 mL juice PO tid

UTI prevention, adult patients

[Possibly Effective]

Dose: 120-1600 mg/day PO divided qd-bid; Alt: 50-1000 mL/day juice PO divided qd-qid

UTI prevention, peds patients

[Possibly Effective]

Dose: 5 mL/kg/day juice PO divided qd-bid; Alt: 50 mL juice PO qd; 0.2 mL/kg/dose syrup PO qd; 100 mL 50% concentrate PO qd; 120 mg PO qd in patients 12-18 yo